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http://www.biomedcentral.com/1471-2180/13/266RESEARCH ARTICLE Open AccessEscherichia coli YmdB regulates biofilm formation
independently of its role as an RNase III
modulator
Taeyeon Kim1†, Juyeon Lee1,2† and Kwang-sun Kim1,3*Abstract
Background: Ribonuclease III (RNase III) activity modulates hundreds of genes in Escherichia coli (E. coli). YmdB, a
member of the macrodomain protein family, is one of known trans-acting regulators of RNase III activity; however,
the significance of its regulatory role in specific bacterial cellular processes and related genes has not been determined.
YmdB overexpression was used to model YmdB-induced RNase III inhibition in vivo, and microarray analysis identified
gene targets and cellular processes related to RNase III inhibition.
Results: The expression of >2,000 E. coli genes was modulated by YmdB induction; 129 genes were strongly regulated,
of which 80 have not been reported as RNase III targets. Of these, ten are involved in biofilm formation. Significantly,
YmdB overexpression also inhibited biofilm formation via a process that is not uniquely dependent upon RNase III
inhibition. Moreover, biofilm formation is interdependently regulated by RpoS, a known stress response regulator and
biofilm inhibitor, and by YmdB.
Conclusions: This is the first global profile of target genes modulated by YmdB-induced RNase III inhibition in
E. coli, and the data reveal a novel, hitherto unrecognized regulatory role for YmdB in biofilm modulation.
Keywords: Ribonuclease III (RNase III), Microarray, Biofilm, Trans-acting regulator, Escherichia coliBackground
RNase III family members cleave double-stranded RNAs
to yield 5′ phosphate and 3′ hydroxyl termini, and are
extensively conserved in prokaryotes and eukaryotes
[1-7]. During bacterial ribosome biogenesis, RNase III
processes the ribosomal RNA (rRNA) precursors [8],
and also mediates the maturation and/or degradation of
different types of transcripts [9], small RNAs [10,11],
and mRNAs containing rnc [12,13] or pnp genes [14].
The structural and mechanistic features of RNase III
have been extensively studied [1-14]; however, questions
remain concerning the cellular control of RNase III
activity under different physiological conditions.* Correspondence: sunny06@kribb.re.kr
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reproduction in any medium, provided the orIn E. coli, some proteins are known as regulators for
endo-RNase activity [15-18]. For example, RraA and
RraB negatively regulate RNase E activity [15,16]. In case
of RNase III, bacteriophage T7 protein kinase [17] and
YmdB [18] identified as an either activator or inhibitor of
RNase III function. The activation process by bacteriophage
T7 protein kinase is through binding to RNase III and
phosphorylates the enzyme on serine [17]. YmdB was
the first RNase III-binding inhibitor to be identified
in vivo using a novel genetic screening approach and,
in common with other RNase regulators, YmdB expression
is modulated by cold- or growth-stress [18]. YmdB, acting
in concert with other uncharacterized stress-mediated
trans-acting factors, facilitates the regulation of RNase III
activity under growth- [18] or osmotic stress conditions
[19]. Several protein identities are proposed for the
trans-acting inhibitor(s) and potential targets of their
inhibition has been suggested; for example, cellular
targets of RNase III activity, such as the RNase III
gene itself, rnc [12,13], pnp [14], and rRNA processing by
YmdB [18] and the level of bdm mRNA encoding a protein. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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factor(s) [19]. The cellular processes required for RNase III
inhibition by trans-acting factor(s) during stress responses
are unclear; however, one post-transcriptional pathway
has been proposed [7], which involves the general
stress-responsive regulator, RpoS [20]. By cleaving the
rpoS mRNA 5′-leader [21], RNase III reduces RpoS
production; the presence of YmdB limits this reaction and
as a consequence, increases RpoS levels, which supports
entry into the stationary phase [7]. This hypothesis behind
this process came from a study that used an RNase III
mutant [21]; however, to clarify and identify new targets of
RNase III inhibition, it is essential to adopt a model that
mimics physiological RNase III inhibition via the induction
of trans-acting factor(s).
The present study investigated RNase III inhibition via
the ectopic expression of the regulatory protein, YmdB,
and identified novel targets of inhibition. We also explored
the mechanism(s) by which biofilm formation is regulated.
Gene expression profiling of the entire E. coli open reading
frame (ORF) following YmdB overexpression was performed
using DNA microarray analysis, and revealed that ~2,000
transcripts were modulated. Of these, 129 genes spanning
ten cellular processes were strongly modulated by YmdB
expression. About 40 of these were similarly controlled by
RNase III, including five novel targets. Moreover, among the
YmdB-modulated genes, ten are reported to be related to
biofilm formation, the presence of which is a universal
feature of bacteria and a component of multicellular
communities [22]. Biochemical analyses indicate that
induction of YmdB strongly inhibits biofilm formation
in a manner similar to that of RpoS, which is a regulator of
general stress responses [20] and a biofilm inhibitor [23-25].
Inhibition occurred via two mechanisms that were either
dependent or independent of RNase III activity. Genetic
studies revealed that the YmdB- and RpoS-induced decrease
in biofilm formation required RpoS and YmdB, respectively.
In conclusion, we have identified a novel role for YmdB as a
modulator of biofilm formation, and revealed how a
trans-acting factor can regulate RNase III activity, as well
as function independently to enable a rapid response to
changing cellular needs.
Methods
Bacterial strains, plasmids, primers, and growth
conditions
Details of the bacterial strains and plasmids used are
given in Additional file 1: Table S1. Primers used for
qPCR analysis and DNA sequencing were synthesized by
Bioneer (Korea) (Additional file 1: Table S2). All estab-
lished mutant strains or chromosomal lacZ fusions were
derived from E. coli BW25113. Analysis of rpoS pro-
moter activity was based on a plasmid, pKSK001, con-
taining promoter region −92 to +10 of the rpoS genefrom the E. coli K12 genome (GenBank U00096.2) sub-
cloned into the lacZ transcriptional fusion vector,
pSP417 [26], after linearization by EcoRI/BamHI. The
lacZ fusion in pKSK001 was recombined onto the
chromosome (KSK003) using the transducing λ phage
system, λRS45 [27], via a double recombination event
and was verified as previously described [18]. Strain
ΔymdB was constructed by eliminating the kana-
mycin cassette (ymdB::kmR) from Keio-ΔymdB as de-
scribed previously [28]. Verification of Keio-ΔymdB [28],
ΔymdB (KSK002), Keio-ΔrpoS [28], or rnc14∙Keio-ΔrpoS
(KSK005) was carried out by colony PCR using primer
pairs ymdB-F/-R or rpoS-F/-R and Emerald PCR premix
(Takara) (Additional file 1: Figure S1), and the PCR
products were read by DNA sequencing analysis using
the same primers (data not shown). Verification of
RNase III mutation was confirmed by Western blot ana-
lysis using antibodies against RNase III (Additional file
1: Figure S1). Bacteria were grown in Luria-Bertani (LB)
broth or on LB plates at 37°C throughout this study. An-
tibiotics were used at the following concentrations:
kanamycin, 50 μg/mL; tetracycline, 10 μg/mL; and chlor-
amphenicol, 30 μg/mL.
Microarray analysis
Total RNA was extracted from IPTG (0.1 mM final con-
centration)-induced E. coli BW25113 cells (at an OD600
of 1.0) containing either pCA24N (−gfp) or ASKA-ymdB
(−) using an RNeasy® Kit (Qiagen) with two additional
DNase treatments. The integrity of the bacterial total RNA
was checked by an Agilent 2100 Bioanalyzer. The cDNA
probes were prepared by reverse transcription with random
priming of total RNA (25 μg) in the presence of aminoallyl-
dUTP for 3 h, followed by coupling of probes with Cy3 dye
(for the reference) or Cy5 dye (for the test sample) (AP Bio-
tech). The Cy3- or Cy5-labeled cDNA probes were purified,
dried, and resuspended in hybridization buffer containing
30% formamide, 5× SSC, 0.1% SDS, and 0.1 mg/mL salmon
sperm DNA. The cDNA probes were mixed together and
hybridized to customized microarray slides (E. coli K12 3 ×
15 K microarray; www.Mycroarray.com). The image of the
slide was scanned with a GenePix 4000B (Axon Instru-
ments, USA) and analyzed by GenePix Pro 3.0 software
(Axon Instruments) to obtain the gene expression ratios
(reference vs. test sample). Microarray data analysis was
performed using Genowiz 4.0™ (Ocimum Biosolutions).
Global lowess (Locally weighted scatter plot smoothing)
method was used for data normalization. The cut-off values
for up- or down-regulated genes in duplicate hybridizations
were 1.5- or 0.6-fold, respectively.
RT-qPCR analysis
The E. coli strains listed in Additional file 1: Table S1
were grown in LB medium to an OD600 of 1.0, and the
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(Qiagen). Reverse transcription and qPCR (RT-qPCR)
analyses were performed using CFX96 (Bio-Rad) with
IQ™ SYBR® Green Supermix (Bio-Rad), as described
previously [29] and gene specific primers designed
by PrimerQuest (www.idtdna.com; Additional file 1:
Table S2). Primer-dimer and self-complementary forma-
tions were checked by melting curve analysis (CFX man-
ager v3.0; Bio-Rad). The 16S rRNA primers were used
for normalization [29].
Crystal violet biofilm assay
The assay was adapted from Nakao et al. [30] with
the following modifications: E. coli were grown in LB broth
for 16 h at 37°C and diluted to 5 × 106 CFU/mL in fresh LB
broth with or without IPTG. Aliquots (800 μL) dis-
pensed into polystyrene tubes (Falcon 352058, BD
Biosciences) and incubated for 24 h at 37°C without
shaking. Each data point represents the mean ± standard
deviation of ten independent cultures.
β-galactosidase activity assays
The β-galactosidase activity from whole cells of
KSK003 (λrpoS’-‘lacZ), KSK004 [SG30013 (λRpoS750::
LacZ)] [31], RS8872 (λpnp’-‘lacZ in rnc+) [32], or RS8942
(λpnp’-‘lacZ in rnc14) [32] overexpressing YmdB from
ASKA-ymdB (−) was determined as described by Miller
[33]. The results are expressed as the means of three inde-
pendent experiments.
Protein gel electrophoresis and Western blot analysis
Overexpression of the YmdB and RpoS proteins was
detected on Coomassie blue-stained 12% Mini-
PROTEAN TGX Precast gels (Bio-Rad). Western
blots for RNase III, YmdB, RpoS, or 6x Histidine-
tagged YmdB were prepared as described [18], probed
with antibodies (1:2,500 dilution) against YmdB,
RNase III [18], RpoS (1RS1: Santa Cruz Biotechnol-
ogy), or 6x Histidine-tagged YmdB (6xHis Epitope
Tag Antibody: Thermo Scientific) and developed with
Clarity™ western ECL substrate (Bio-Rad). To normalize the
signals, antibodies against S1 protein [34] was used as a
reference probe (1:100,000 dilution). Anti-rabbit IgG:
HRP or anti-mouse IgG:HRP conjugates (Promega; 1:5000
dilution) were used for YmdB/RNase III/S1 proteins or
RpoS/6xHistidine tagged YmdB, respectively. Specific pro-
teins were imaged using MyECL and quantified with
myImage Analysis software (Thermo Scientific).
Results
Analysis of the E. coli transcriptome under conditions
mimicking those of an RNase III mutant
To identify which pathways and related genes are me-
diated by YmdB-modulated RNase III inhibition, agenome-wide analysis of mRNA abundance at single
gene resolution was performed. In these experiments,
total steady-state RNA extracted from IPTG-induced
exponentially grown cells expressing either ASKA-
ymdB (a part of the ASKA (−) library: a complete set
of cloned individual E. coli genes encoding proteins
with 6x histidines at the N-terminal end and no GFP
fusion at the C-terminal end [35]); or pCA24N (a
control vector without GFP at the C-terminal end)
[29] were analyzed on customized ORF microarray
chips. Duplicate arrays were performed with biological rep-
licates to minimize experimental artifacts, and the gene ex-
pression profiles of 4,289 genes were averaged and
analyzed. YmdB overexpression modulated the relative
abundance of more than 2,000 transcripts (data not shown).
Of these, 129 genes were strongly regulated (changes in ex-
pression of either >1.5 or <0.6 fold) (Additional file 1:
Table S3). YmdB was previously identified as an RNase III
regulator [18]; thus, we examined the number of YmdB-
modulated genes that were related to the down-regulation
of RNase III activity to identify RNase III/YmdB-regulatory
genes. The microarray data related to YmdB overexpression
were compared with the tiling array data for an RNase III
mutant [36], in which 592 genes were affected by the
absence of RNase III. Of 127 coding genes from the
tiling array data, 47 are known RNase III targets and,
of these, 37 were similarly regulated by YmdB and the
RNase III mutant (Additional file 1: Table S3). This sug-
gests that YmdB modulates these genes by down-
regulating RNase III activity. However, 80 genes that
were not previously regarded as RNase III targets also
appeared to be modulated via an as yet uncharacterized
YmdB function(s). When the 80 genes were classified ac-
cording to the biological process in which they are in-
volved, we identified ten different cellular processes that
were modulated by YmdB induction (Table 1). Therefore,
the data indicate that YmdB, either as an RNase III regula-
tor or by itself, participates in the regulation of multiple
cellular processes within E. coli.
Identification of new RNase III targets regulated by YmdB
Using the results shown in Additional file 1: Table S3,
genes that showed the highest changes in expression
(>2-fold change) were selected for quantification by real-
time quantitative PCR (RT-qPCR). These genes com-
prised confirmed (mltD, pnp, plsX, and ahpF) [14,36]
and unconfirmed (pspA, pspB, pspC, pspD, and ahpC)
RNase III targets. For all known RNase III-target genes,
increased expression was observed in the RNase III
mutant (rnc14), which correlated with the YmdB
overexpression data (Table 2). Moreover, gene expres-
sion decreased or remained at the same level in a ymdB
knockout strain in which RNase III activity was upregulated,
suggesting that YmdB-mediated inhibition of RNase III
Table 1 Classification of up- or down-regulated 80 genes when YmdB was overexpressed
Functions Gene No. of gene Go term ID
Transport dppA, emrA, exbB, exuT, fdx, fecI, gutM, icd, mntH, nrfA2, proP, srlA2, srlB2, srlE2,













Transcription/replication cspB, cspG, fecI, gutM, lacI, mprA, mukF, mqsR3, pspB1,2, pspC1,3, relE3, rpoA, rpoB,







Cellular responses cspB, cspG, emrA, mprA, nusA, pspB1,3, pspC1,3, pspD1,3, 13 GO:0006950
GO:0009266
GO:0009271
relE3, rplD, rpoE3, rseA3, sseA GO:0009408
GO:0009409
GO:0046677




Translation mqsR3, pheT, rplC, rplD, rpsA, rpsJ, yhbC, relE3 8 GO:0006412
GO:0017148
Metabolic process fabD, lacI, srlA2, srlB2, srlD2, srlE2, sucA2, ycjM 8 GO:0008152
Oxidation-reduction ahpC3, nrfA2, srlD2, sucA2, torZ, ygjR 6 GO:0055114
Biosynthesis fabD 1 GO:0006633
GO:0006654
GO:0008610
Cell cycle mukF 1 GO:0007049
GO:0051301
Nucleotide binding yeeZ3 1 GO:0000166
GO:0005524
Genes 1up- (>3-fold) or 2down-(<0.5-fold) regulated by YmdB overexpression were indicated. Detailed quantitative data are shown in Additional file 1: Table S3.
3Gene is related to biofilm formation in literature, even though GO term analysis (www.ecocyc.org) did not classify it as such.
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ously known to be RNase III targets. The abundance of
mRNAs for the unconfirmed RNase III target genes was
measured in the RNase III mutant and thencompared with the data regarding YmdB overexpres-
sion (Table 2). From five genes, the expression of the
pspB, pspC, and ahpC genes was slightly increased
upon both YmdB overexpression and RNase III
Table 2 Relative abundance of RNase III-dependent or -independent transcripts by different level of YmdB or RNase III
RNase III-dependent genes Microarray1 qPCR-ΔymdB2 qPCR-YmdB3 qPCR-rnc144
mltD 3.66 3.06 ± 0.04 7.37 ± 0.03 39.80 ± 0.01
PnP 3.06 0.84 ± 0.01 3.27 ± 0.36 8.02 ± 0.02
plsX 3.01 2.98 ± 0.01 2.86 ± 0.31 21.37 ± 0.01
ahpF 2.48 0.90 ± 0.02 3.34 ± 0.33 7.72 ± 0.01
yhdE 2.26 1.90 ± 0.01 2.37 ± 0.20 3.93 ± 0.01
RNase III-independent genes Microarray1 qPCR-ΔymdB2 qPCR-YmdB3 qPCR-rnc144
pspB 5.18 0.88 ± 0.13 1.53 ± 0.01 1.36 ± 0.01
pspA 4.46 0.78 ± 0.01 1.50 ± 0.01 1.15 ± 0.01
pspD 4.30 0.82 ± 0.01 2.45 ± 0.06 1.86 ± 0.02
pspC 3.86 1.01 ± 0.01 1.59 ± 0.02 1.38 ± 0.02
ahpC 2.81 0.67 ± 0.01 3.73 ± 0.01 3.30 ± 0.01
1Fold-change of each transcript levels from microarray analysis (Additional file 1: Table S3): YmdB overexpression from ASKA-ymdB(−) vs pCA24N (−gfp) in
wild-type (BW25113) background.
Relative ratios of each transcript levels determined by qPCR with specific primers (Additional file 1: Table S2) are indicated: 2ymdB knockout (ΔymdB: KSK002) vs
BW25113 (ymdB), 3YmdB overexpression from ASKA-ymdB (−) vs pCA24N (−gfp) or 4RNase III mutant (rnc14:KSK001) vs BW25113 (rnc+).
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be new RNase III targets regulated by YmdB.
Identification of YmdB as a protein that inhibits biofilm
formation
The results obtained thus far suggest a role for YmdB in
biofilm synthesis. Ten genes related to biofilm formation
[37-40] were modulated by YmdB overexpression
(Table 1); in particular, genes induced within the biofilm
were strongly upregulated, including rpoE [41] and
pspABCDE [41,42]. Additionally, rpoS and bdm, both
known targets of RNase III and related to either the
down- or up-regulation of biofilm formation [19,21,36],
were upregulated (by ~1.5- and 1.8-fold, respectively).
To investigate this further, biofilm formation by
BW25113 cells containing either pCA24N (−gfp) or
ASKA-ymdB (−) was measured after 24 h of growth
without agitation in LB containing different concentra-
tions of IPTG (0 to 0.1 mM). Compared with cells har-
boring the control vector, increased expression of YmdB
inhibited biofilm formation by up to 80% in the presence
or absence of IPTG (Figure 1A). The effect was linearly
correlated with IPTG concentration (10-6 to 10-1 mM),
with no further reduction observed above 1 mM IPTG
(data not shown). The physiological relevance of this in-
hibitory effect of YmdB is shown in Figure 1B. The total
relative level of YmdB protein was assessed by Western
Blotting [18] and was found to increase by 2.2- to 5.7-
fold in the presence of increasing concentrations of
IPTG (Figure 1B) (increased YmdB expression in the ab-
sence of IPTG results from the leaky lac promoter in
the ASKA plasmids) [35]. The changes in YmdB levels
are similar to those observed in vivo following growth-
or cold-stress (2- to 8-fold) [18] and are thus physiolo-
gically relevant.RNase III does not affect biofilm inhibition by YmdB
The YmdB protein regulates RNase III activity through
the formation through the proposed formation of an
RNase III/YmdB heterocomplex [18]; hence, it was im-
portant to clarify whether the biofilm phenotype mediated by
ectopic expression of YmdB is similar to that mediated by
RNase III inhibition. Biofilm formation in the absence of
RNase III (rnc14) increased by ~52% (Figure 2A), implying
that inhibition of biofilm formation is independent of
RNase III/YmdB heterocomplex, and that an alternative,
hitherto uncharacterized, function of YmdB exists. To
verify this possibility, we measured the inhibition of
biofilm formation in the presence of YmdB overexpression
(confirmed in Figure 2B) against an rnc + and rnc14
background. The results showed that inhibition was
almost the same between the wild-type strain (~70%)
and the strain lacking RNase III (~67%) (Figure 2A).
By contrast, processing of pnp’-‘lacZmRNA, a known target
for YmdB-mediated inhibition of RNase III activity [18], is
fully dependent on RNase III (Additional file 1: Figure S2).
Taken together, these results indicate that YmdB over-
expression inhibits biofilm formation via an RNase
III-independent pathway.
RpoS is required for the inhibition of biofilm formation
by YmdB
While it was clear that YmdB induction decreased
biofilm formation (Figure 1), biofilm formation also
decreased by ~ 35% in the absence of ymdB (ΔymdB)
gene in the chromosome (Figure 3A). This could indicate
that YmdB is involved in, but not essential for, the inhibition
of biofilm formation in E. coli, or that increased levels of
YmdB affect biofilm formation by modulating associated
cellular proteins and their pathways. To test this hypothesis,
we sought to identify candidate genes whose mRNA levels
Figure 1 YmdB inhibits biofilm formation. (A) Inhibition of biofilm formation by YmdB overexpression. E. coli cells containing either pCA24N
(−gfp) or ASKA-ymdB (−) were grown at 37°C for 24 h in LB medium containing 0 to 10-1 mM IPTG. Biofilm formation was analyzed, and mean
values calculated (n = 10, p = 0.05). (B) Western blot analysis of YmdB expression levels. Total cellular proteins from the cells described in (A) were
reacted with antibodies against YmdB or S1. Changes in YmdB protein levels from ASKA-ymdB induced by IPTG were determined relative to the
levels of chromosomally-encoded YmdB protein derived from pCA24N (-gfp) vector-containing cells (indicated below).
Figure 2 YmdB inhibits biofilm formation in an RNase III-independent manner. (A) Effect of the presence or absence of RNase III on
YmdB-mediated inhibition of biofilm formation. Biofilm formation by BW25113 (rnc+) or KSK001 (rnc14) cells with or without plasmid [pCA24N (−gfp)
or ASKA-ymdB (−)] was measured using cells grown at 37°C for 24 h in LB medium containing IPTG (0.1 mM final) Mean values (n = 10, p = 0.05) are
shown. “Relative biofilm formation” for KSK001 and ASKA-ymdB (in BW25113 or KSK001) was determined relative to the biofilm formation by each
control set (BW25113 or pCA24N; set to 1.0). (B) Expression levels of YmdB. The expression of YmdB (His-YmdB) in total cell lysates (from A) was
detected by immunoblotting with 6xHis Epitope Tag antibody as described in Methods. S1 protein level was used as loading control.
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Figure 3 Interdependency on YmdB and RpoS for biofilm formation. (A) Effect of knocking out ymdB or rpoS on biofilm formation. Biofilm
formation was measured in wild-type (ymdB + or rpoS+), KSK002 (ΔymdB) and rpoS mutant (Keio-ΔrpoS) cells. (B) Dependency of RpoS and YmdB
phenotype on biofilm formation. The effect of ectopic expression of RpoS or YmdB in the absence of ymdB or rpoS, respectively, on biofilm
formation was determined. (C) Expression of RpoS and YmdB. Protein expression was detected by immunoblotting using antibodies against RpoS
and 6xHistidine tagged YmdB (His-YmdB) as described in Methods. S1 protein level was used as a loading control. All biofilm formation data were
obtained as described in Methods. Data represent the mean values from ten independent experiments.
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effect on the biofilm phenotype. One strong candidate is
RpoS, a stress-responsive sigma factor [21], which when
overexpressed led to a reduction in biofilm formation
(Figures 3B,C; [25]). To determine whether YmdB-mediated
inhibition of biofilm formation is dependent on the
presence or absence of rpoS, we measured biofilm
formation in an rpoS knockout strain (Keio-ΔrpoS).
Biofilm formation was activated in the rpoS knockout
(Figures 3A,C). Subsequent introduction of a plasmid
overexpressing YmdB only decreased biofilm inhibition by12% in the rpoS knockout (Figure 3B) whereas it re-
sulted in 70% inhibition in wild-type cells (Figure 2A);
thus, the inhibition of biofilm formation by YmdB is
RpoS-dependent.
Both YmdB and RpoS interdependently regulate gene
expression and activity on biofilm formation
Since YmdB is transcriptionally activated by RpoS [18] and
the level of rpoS transcripts was increased by YmdB overex-
pression, it is possible that YmdB modulates RpoS expres-
sion. YmdB could affect this change in rpoS transcript levels
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or by acting as an effector protein for the factor(s) involved
in rpoS transcription. We found that YmdB overexpression
had no effect on rpoS promoter activity (data not shown),
thereby excluding any role as a transcription factor. A linearFigure 4 Regulation of RpoS levels and activity by YmdB. (A) Effect of Ym
[31] strains containing either pCA24N (−gfp) or ASKA-ymdB (−) were grown to
OD600 = 1.0. Aliquots were then assayed for β-galactosidase activity. Data repre
level of RpoS. Total lysates prepared from the cell described in (A) and from Ke
Keio-ΔrpoS strain is included to show the specificity of the antibody. The relativ
determined. (C) Determination of steady-state levels of rpoS transcript induced
KSK002 (ΔymdB), KSK001 (rnc14) or BW25113 cells containing either pCA24N (−
RNA-specific primer sets listed in Additional file 1: Table S2 and then comparedrelationship between rpoS transcript levels and RpoS protein
levels was then investigated following YmdB induction, and
similar increases (~2.5-fold) in the induced β-galactosidase
activity of the rpoS’-‘lacZ protein fusion and the RpoS
protein level were observed (Figures 4A,B). Moreover, thedB on in vivo expression levels of RpoS. KS004 [SG30013 (λRpoS750::LacZ]
OD600 = 0.2, induced by IPTG (0.1 mM final), and further grown to
sent the mean values from n = 3 experiments (p = 0.05). (B) Expression
io-ΔrpoS cells were immunoblotted antibodies against RpoS and S1. The
e levels of RpoS normalized against S1 protein are shown. ND, not
by YmdB. cDNA synthesized from total RNA obtained from BW25113,
gfp) or ASKA-ymdB (−) were qPCR amplified using the rpoS- or 16S
. Data represent the mean values from triplicate experiments.
Figure 5 A schematic model of biofilm formation and gene
expression involving YmdB, RpoS, and RNase III. Two different
pathways for biofilm formation are proposed: an RNase III-dependent
pathway in which other uncharacterized factor(s) inhibit RNase III activity,
thereby upregulating biofilm formation, and an RNase III-independent
pathway in which both YmdB and RpoS interdependently regulate the
inhibition of biofilm formation. In terms of gene expression, the level of
RpoS is post-transcriptionally regulated by YmdB either directly
or indirectly via the inhibition of RNase III activity [18,20], while the level
of YmdB is regulated transcriptionally by the RpoS protein [18].
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oppositely regulated in the absence of chromosomal
ymdB. Additionally, the level of rpoS transcript following
YmdB overexpression was lower than that in the RNase
III mutant strain. These data suggest that YmdB-mediated
regulation of RNase III activity alone cannot fully regulate
the processing of the 5′ UTR of rpoS mRNA. Because
RpoS can negatively regulate biofilm formation by itself
(Figure 3B) and is also required for complete YmdB func-
tion (Figure 3B), it is a matter of debate whether YmdB
can modulate RpoS activity. When the RpoS protein was
overexpressed in a wild-type and in an ymdB knockout
strain, RpoS-mediated inhibition of biofilm formation was
decreased from 70% to 43% (Figure 3B). This, when taken
together with the other data, suggests that the regulation
of RpoS function during biofilm formation is dependent
upon YmdB. Moreover, RpoS overexpression phenotype
on biofilm inhibition was not dependent upon the pres-
ence of RNase III activity (Additional file 1: Figure S3).
Thus, YmdB is a novel post-transcriptional regulator of
RpoS levels that acts independently of RNase III.
Discussion
The results presented herein demonstrate that YmdB is
a major regulator of RNase III activity in E. coli, modulating
more than 30% of the genes targeted by RNase III. In
addition, the results of a microarray analysis following
YmdB overexpression (which identified changes in biofilm-
related genes and a decrease in biofilm formation) indicate
a novel role for YmdB as a modulator of biofilm formation.
Previous results indicated that overexpression of RpoS was
associated with decreased biofilm formation [25]. Our
microarray, qPCR, and Western blotting data showed that
overexpression of YmdB increased the levels of RpoS
(Additional file 1: Tables S3, Figures 2, 3 and 4). Moreover,
YmdB modulated RpoS levels and activity of biofilm
formation (Figures 3, 4). Thus, we propose a model to
illustrate the multiple roles played by YmdB during gene
expression and biofilm formation (Figure 5).
The 5′ UTR of rpoS mRNA is a known target of
RNase III and its levels increase when RNase III activity
is ablated [21]. Because biofilm formation is influenced
by RpoS levels, it may be proposed that the rpoS mRNA
is responsive to YmdB-directed RNase III inhibition.
However, this is not the case because the decrease in
biofilm formation following YmdB expression was not
reversed in the absence of RNase III (Figure 2), suggesting
that regulation of RNase III activity by YmdB is not essen-
tial for the inhibition of biofilm formation. Thus, the major
mechanism underlying biofilm regulation by YmdB appears
to be RNase III-independent (Figure 5).
A screen of potential regulatory gene(s) with a YmdB-
mediated phenotype demonstrated that RpoS is necessary
for inhibiting biofilm formation (Figure 3); RpoS activatesthe transcription of ymdB [18]; thus, it is highly plausible
that the RpoS gene is an upstream regulator of YmdB
transcription and the resultant phenotypes. Conversely,
the possibility that YmdB is a transcription factor that
activates rpoS transcription was initially suggested by ob-
servations that RpoS levels were increased by YmdB over-
expression, and that YmdB and RpoS are both required
for the decrease in biofilm formation. However, this theory
was rejected because increases in YmdB expression had no
effect on promoter activity (data not shown). Hence,
YmdB-induced modulation of RpoS levels must occur via
post-transcriptional regulation (Figure 4). It is also possible
that YmdB modulates other rpoS transcription factor(s),
although we have not identified which other tran-
scription factors are required for this response. Over-
all, the data suggest that YmdB and RpoS are co-
regulators of biofilm formation (Figure 5).
The identification of a novel role for YmdB is not
altogether surprising, since eukaryotic macrodomain
proteins can have multiple roles [43,44], and YmdB
has additional functions in bacteria [45,46]. For instance,
in E. coli YmdB deacetylates the sirtuin product of
O-acetyl-ADP-ribose and reforms ADP ribose [45].
The present study reveals that YmdB modulates the
expression of genes involved in physiologically important
pathways (Table 1); hence, YmdB could act as a general
regulator in a variety of cellular processes. Further examin-
ation of such a potential role for YmdB and its family
members in bacteria is necessary. YmdB is also required to
be coexpressed for the complementation of a function of
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[45]. ClsC utilizes phosphatidylethanolamines (PE) as the
phosphatidyl donor to phosphatidylglycine (PG) to form
cardiolipin (CL) [46]. While YmdB is apparently not a
direct modulator of that pathway (since changes in clsC
(ymdC) gene expression in the microarrays were negligible
(a 1.1-fold increase only); (data not shown), it may modu-
late it indirectly via the action of the fatty acid biosynthesis
gene, fabD (Table 1), on the CL synthesis-regulating gene;
however, such a role has not been confirmed.
The ectopic expression of YmdB almost completely
regulates RNase III activity with respect to several targets,
including pnp, rnc and ribosomal RNA processing
(Additional file 1: Figure S2) [6]; however, biofilm forma-
tion is not solely dependent upon YmdB-directed RNase
III regulation, suggesting that gene expression data will be
useful for identifying unknown RNase III-independently
regulated YmdB functions.
Several trans-acting factors that modulate the RNase
activity of both exo- and endo-RNases have been identified
in E. coli [15-18,47,48]. Among these four trans-acting
regulatory proteins for endo-RNase activity have been well
characterized in E. coli: RraA [15] and RraB [16] for RNase
E, and bacteriophage T7 protein kinase [17] and YmdB [18]
for RNase III. The presence of homologs in other species
suggests such regulation of endo-RNase activity is generally
required for bacterial physiology. Recently, gene expression
profiling revealed a role for RraA in regulating the SOS
response, a mechanism which responds to the stress caused
by DNA damage [15,49]. RNase III modulates approxi-
mately 12% (592 genes) of the E. coli genome [35]; using
YmdB-mediated down-regulation of RNase III rather than
an RNase III mutant retains the ability to measure the
effect of trans-acting factor(s) and hence the correct physio-
logical modulation of RNase III. Because YmdB regulates
the turnover of approximately 30% of the target genes
of RNase III (Additional file 1: Table S3) and the rpoS
level is not completely regulated by YmdB (Figure 4),
either other regulator(s) that result RNase III mutant-
like conditions must be present or YmdB partially
regulates the physiology of the RNase III-mutant to
induce the up-regulation of an RNase III activator
that has yet to be identified.
Conclusions
The data presented herein show that YmdB functions
both to regulate RNase III activity and to modulate
bacterial biofilm formation; therefore, YmdB seems to
be a multifunctional bacterial macrodomain protein,
similar to that in eukaryotic cells. Furthermore, this
protein will make it possible to design a more intelligent
synthetic scaffold for producing bacterial cells that
modulate difficult-to-treat pathogens that depend upon
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